Saturday December 7, 2019

Pharma giant buys maker of ‘female Viagra’

22nd August, 2015
4
Valeant’s acquisition will spearhead a ‘portfolio’ of female medications

Canadian pharmaceutical giant Valeant has agreed to buy Sprout Pharmaceuticals, the maker of Addyi, a new drug nicknamed the ‘female Viagra’, for about $1 billion.

“Delivering a first-ever treatment for a commonly reported form of female sexual dysfunction gives us the perfect opportunity to establish a new portfolio of important medications that uniquely impact women.”

J Michael Pearson, Valeant chairman and chief executive

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Mortgage gouging by banks does not serve society well

Matt Cooper | 2 weeks ago